Soricimed

About:

Soricimed Biopharma operates as a clinical-stage drug and diagnostic development company.

Twitter/X: Soricimed

Top Investors: New Brunswick Innovation Foundation

Description:

Soricimed is a clinical-stage company with a focus on the development of targeted treatments for cancer. It specializes in developing delivery peptides and therapeutics for several types of solid tumor cancers.

Total Funding Amount:

$3.26M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Moncton, New Brunswick, Canada

Founded Date:

2005-01-01

Contact Email:

info(AT)soricimed.com

Founders:

John (Jack) M. Stewart

Number of Employees:

11-50

Last Funding Date:

2022-07-12

IPO Status:

Private

Industries: